Cellular Microbiology · 2016 · 13 citations · 31 references
Life SciencesImmunologyPharmacologyImmunizationImmunopharmacologyVaccinologyAdaptive Immune ResponsesCell-mediated ImmunityFungal ImmunologyHumoral ImmunityImmune FunctionImmune Response To VaccinationBovine Serum AlbuminCandida Albicans InfectionEx Vivo ModelsFungal VaccinesHost Immune Response To CandidaImmune Cell Proliferation InhibitionMicrobial Growth InhibitionVaccination-induced Immunity
Synthetically prepared bovine serum albumin (BSA) conjugate of linear β-(1 → 3)-nonaglucoside ligand (G9) has been applied as a biological response immunomodulator in vivo and ex vivo. Active immunization of Balb/c mice revealed effective induction of specific humoral responses in comparison with Candida β-D-glucan and Candida whole cells. Induced post-vaccination serum exhibited a growth-inhibition effect on the multi-azole-resistant clinical strain Candida albicans CCY 29-3-164 in experimental mucocutaneous infection ex vivo. Evaluation of immune cell proliferation and the cytotoxic potential of the G9-ligand has revealed its bioavailability and an immunostimulative effect in vaccination-sensitized Balb/c mice splenocytes and RAW 264.7 macrophages.
31
Mary E. Brandt · Emerging infectious diseases · 2002 · 647 citations · Full text
A novel glyco-conjugate vaccine against fungal pathogens
Antonella Torosantucci, Carla Bromuro, Paola Chiani et al. · The Journal of Experimental Medicine · 2005 · 443 citations · Full text
Douglas W. Lowman, Rachel R. Greene, Daniel W. Bearden et al. · Journal of Biological Chemistry · 2013 · 131 citations · Full text